ESCO Technologies reported solid Q3 2020 results, demonstrating resilience through diversity and effective cost management, achieving Adjusted EBITDA consistent with Q3 2019 despite sales decrease.
Q3 2020 GAAP EPS was $0.72, including $0.04 per share of COVID-19 related costs; Adjusted EPS was $0.76.
Q3 2020 Adjusted EBITDA was $35 million, consistent with Q3 2019.
Test segment showed strength with a 9% sales increase and nearly 16% EBIT margin.
Ending backlog remains strong at $551 million, a 22% increase from the start of the year.
Given the continued uncertainty regarding the extent and duration of these economic circumstances, it is difficult to predict how our future operations will be affected using our normal forecasting methodologies, therefore, the Company will continue the suspension of fiscal year 2020 guidance.